Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular

Detalhes bibliográficos
Ano de defesa: 2018
Autor(a) principal: Faria Junior, Geraldo Magela de lattes
Orientador(a): Mattos, Luiz Carlos de lattes
Banca de defesa: Dias, Ana Lívia Silva Galbiatti lattes, Silva, Letícia de Azevedo lattes
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Faculdade de Medicina de São José do Rio Preto
Programa de Pós-Graduação: Programa de Pós-Graduação em Ciências da Saúde
Departamento: Faculdade 1::Departamento 1
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://bdtd.famerp.br/handle/tede/534
Resumo: C-C chemokine receptor type 5 (CCR5) is a chemokine receptor that influences the immune response to infectious and parasitic diseases. Objective: This study aimed to determine whether the CCR5Δ32 and CCR5 59029 A/G polymorphisms are associated with the development of ocular toxoplasmosis in humans. Methods: Patients with positive serology for Toxoplasma gondii were analyzed and grouped as "with ocular toxoplasmosis" (G1: n = 160) or "without ocular toxoplasmosis" (G2: n = 160). A control group (G3) consisted of 160 individuals with negative serology. The characterization of the CCR5Δ32 and CCR5 59029 A/G polymorphisms was by PCR and by PCRRFLP, respectively. For the statistical analysis, chi-square and Fisher's exact test were performed for comparisons and multivariate logistic regression. Results: The difference between groups in respect to the mean age was statistically significant (G1 vs.G2: p-value <0.0001; t = 7.21; DF = 318; G1 vs.G3: p-value <0.0001; t = 4.32; DF = 318; G2 vs. G3: p-value <0.0001; t = 9.62; DF = 318). The Nagelkerke r² value was 0.040. There were statistically significant differences for the CCR5/CCR5 (p-value = 0.008; OR = 0.261), AA (p-value = 0.007; OR = 2.974) and AG genotypes (p-value = 0.018; OR = 2.447) between G1 and G2. Conclusion: Individuals with the CCR5/CCR5 genotype and simultaneously with the CCR5- 59029 AA or AG genotypes have a greater risk of developing ocular toxoplasmosis (4% greater), which may be associated with a strong and persistent inflammatory response in ocular tissue.
id FMRP_f54640f78de245f92482cde0fb35c7b5
oai_identifier_str oai:localhost:tede/534
network_acronym_str FMRP
network_name_str Biblioteca Digital de Teses e Dissertações da FAMERP
repository_id_str
spelling Mattos, Luiz Carlos dehttp://lattes.cnpq.br/1355463443978857Dias, Ana Lívia Silva Galbiattihttp://lattes.cnpq.br/2384088642223516Silva, Letícia de Azevedohttp://lattes.cnpq.br/218624187496802408752408604http://lattes.cnpq.br/0305516543621586Faria Junior, Geraldo Magela de2019-05-31T18:18:41Z2018-09-26Faria Junior, Geraldo Magela de. Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular. 2018. 57 f. Dissertação (Programa de Pós-Graduação em Ciências da Saúde) - Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto.1418http://bdtd.famerp.br/handle/tede/534C-C chemokine receptor type 5 (CCR5) is a chemokine receptor that influences the immune response to infectious and parasitic diseases. Objective: This study aimed to determine whether the CCR5Δ32 and CCR5 59029 A/G polymorphisms are associated with the development of ocular toxoplasmosis in humans. Methods: Patients with positive serology for Toxoplasma gondii were analyzed and grouped as "with ocular toxoplasmosis" (G1: n = 160) or "without ocular toxoplasmosis" (G2: n = 160). A control group (G3) consisted of 160 individuals with negative serology. The characterization of the CCR5Δ32 and CCR5 59029 A/G polymorphisms was by PCR and by PCRRFLP, respectively. For the statistical analysis, chi-square and Fisher's exact test were performed for comparisons and multivariate logistic regression. Results: The difference between groups in respect to the mean age was statistically significant (G1 vs.G2: p-value <0.0001; t = 7.21; DF = 318; G1 vs.G3: p-value <0.0001; t = 4.32; DF = 318; G2 vs. G3: p-value <0.0001; t = 9.62; DF = 318). The Nagelkerke r² value was 0.040. There were statistically significant differences for the CCR5/CCR5 (p-value = 0.008; OR = 0.261), AA (p-value = 0.007; OR = 2.974) and AG genotypes (p-value = 0.018; OR = 2.447) between G1 and G2. Conclusion: Individuals with the CCR5/CCR5 genotype and simultaneously with the CCR5- 59029 AA or AG genotypes have a greater risk of developing ocular toxoplasmosis (4% greater), which may be associated with a strong and persistent inflammatory response in ocular tissue.O receptor de quimiocinas C-C tipo 5 (CCR5) é um receptor de quimiocinas que influencia a resposta imune às doenças infecciosas e parasitárias. Objetivo: Este estudo teve como objetivo determinar se os polimorfismos CCR5Δ32 e CCR5 59029 A / G estão associados ao desenvolvimento da toxoplasmose ocular em humanos. Métodos: Pacientes com sorologia positiva para Toxoplasma gondii foram analisados e agrupados como "com toxoplasmose ocular" (G1: n = 160) ou "sem toxoplasmose ocular" (G2: n = 160). Um grupo controle (G3) consistiu de 160 indivíduos com sorologia negativa. A caracterização dos polimorfismos CCR5Δ32 e CCR5 59029 A / G foi por PCR e por PCR-RFLP, respectivamente. Para a análise estatística foi realizado teste qui-quadrado e exato de Fisher para as comparações e regressão logística multivariada. Resultados: A diferença entre os grupos em relação à idade média foi estatisticamente significante (G1 vs. G2: p <0,0001; t = 7,21; DF = 318; G1 vs. G3: p <0,0001; t = 4,32; DF = 318; G2 vs G3: valor de p <0,0001; t = 9,62; DF = 318). O valor de Nagelkerke r² foi de 0,040. Houve diferenças estatisticamente significantes para os genótipos CCR5 / CCR5 (p-valor = 0,008; OR = 0,261), AA (p-valor = 0,007; OR = 2,974) e AG (p-valor = 0,018; OR = 2,447) entre G1 e G2. Conclusão: Indivíduos com o genótipo CCR5 / CCR5 e simultaneamente com os genótipos CCR5-59029 AA ou AG têm maior risco de desenvolver toxoplasmose ocular (4% maior), o que pode estar associado a uma forte e persistente resposta inflamatória no tecido ocular.Submitted by Suzana Dias (suzana.dias@famerp.br) on 2019-05-31T18:18:41Z No. of bitstreams: 1 GeraldoMageladeFariaJunior_Dissert.pdf: 1319895 bytes, checksum: 4d03ecdd537b8863699881831f5819ab (MD5)Made available in DSpace on 2019-05-31T18:18:41Z (GMT). No. of bitstreams: 1 GeraldoMageladeFariaJunior_Dissert.pdf: 1319895 bytes, checksum: 4d03ecdd537b8863699881831f5819ab (MD5) Previous issue date: 2018-09-26Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESapplication/pdfporFaculdade de Medicina de São José do Rio PretoPrograma de Pós-Graduação em Ciências da SaúdeFAMERPBrasilFaculdade 1::Departamento 1Polimorfismo GenéticoToxoplasmoseToxoplasmose OcularPolymorphism, GeneticToxoplasmosisToxoplasmosis, OcularCIENCIAS DA SAUDEAvaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocularinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis-695441085367880657450050060060030662648750962450687654494148233069292075167498588264571info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da FAMERPinstname:Faculdade de Medicina de São José do Rio Preto (FAMERP)instacron:FAMERPORIGINALGeraldoMageladeFariaJunior_Dissert.pdfGeraldoMageladeFariaJunior_Dissert.pdfapplication/pdf13198954d03ecdd537b8863699881831f5819abMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-82165bd3efa91386c1718a7f26a329fdcb468MD51http://bdtd.famerp.br/bitstream/tede/534/2/GeraldoMageladeFariaJunior_Dissert.pdfhttp://bdtd.famerp.br/bitstream/tede/534/1/license.txttede/5342019-05-31 15:18:41.738oai:localhost: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Biblioteca Digital de Teses e Dissertaçõeshttp://bdtd.famerp.br/PUBhttps://bdtd.famerp.br/oai/requestsbdc@famerp.br||joao.junior@famerp.bropendoar:47112019-05-31T18:18:41Biblioteca Digital de Teses e Dissertações da FAMERP - Faculdade de Medicina de São José do Rio Preto (FAMERP)false
dc.title.por.fl_str_mv Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular
title Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular
spellingShingle Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular
Faria Junior, Geraldo Magela de
Polimorfismo Genético
Toxoplasmose
Toxoplasmose Ocular
Polymorphism, Genetic
Toxoplasmosis
Toxoplasmosis, Ocular
CIENCIAS DA SAUDE
title_short Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular
title_full Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular
title_fullStr Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular
title_full_unstemmed Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular
title_sort Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular
author Faria Junior, Geraldo Magela de
author_facet Faria Junior, Geraldo Magela de
author_role author
dc.contributor.advisor1.fl_str_mv Mattos, Luiz Carlos de
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/1355463443978857
dc.contributor.referee1.fl_str_mv Dias, Ana Lívia Silva Galbiatti
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/2384088642223516
dc.contributor.referee2.fl_str_mv Silva, Letícia de Azevedo
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/2186241874968024
dc.contributor.authorID.fl_str_mv 08752408604
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/0305516543621586
dc.contributor.author.fl_str_mv Faria Junior, Geraldo Magela de
contributor_str_mv Mattos, Luiz Carlos de
Dias, Ana Lívia Silva Galbiatti
Silva, Letícia de Azevedo
dc.subject.por.fl_str_mv Polimorfismo Genético
Toxoplasmose
Toxoplasmose Ocular
topic Polimorfismo Genético
Toxoplasmose
Toxoplasmose Ocular
Polymorphism, Genetic
Toxoplasmosis
Toxoplasmosis, Ocular
CIENCIAS DA SAUDE
dc.subject.eng.fl_str_mv Polymorphism, Genetic
Toxoplasmosis
Toxoplasmosis, Ocular
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE
description C-C chemokine receptor type 5 (CCR5) is a chemokine receptor that influences the immune response to infectious and parasitic diseases. Objective: This study aimed to determine whether the CCR5Δ32 and CCR5 59029 A/G polymorphisms are associated with the development of ocular toxoplasmosis in humans. Methods: Patients with positive serology for Toxoplasma gondii were analyzed and grouped as "with ocular toxoplasmosis" (G1: n = 160) or "without ocular toxoplasmosis" (G2: n = 160). A control group (G3) consisted of 160 individuals with negative serology. The characterization of the CCR5Δ32 and CCR5 59029 A/G polymorphisms was by PCR and by PCRRFLP, respectively. For the statistical analysis, chi-square and Fisher's exact test were performed for comparisons and multivariate logistic regression. Results: The difference between groups in respect to the mean age was statistically significant (G1 vs.G2: p-value <0.0001; t = 7.21; DF = 318; G1 vs.G3: p-value <0.0001; t = 4.32; DF = 318; G2 vs. G3: p-value <0.0001; t = 9.62; DF = 318). The Nagelkerke r² value was 0.040. There were statistically significant differences for the CCR5/CCR5 (p-value = 0.008; OR = 0.261), AA (p-value = 0.007; OR = 2.974) and AG genotypes (p-value = 0.018; OR = 2.447) between G1 and G2. Conclusion: Individuals with the CCR5/CCR5 genotype and simultaneously with the CCR5- 59029 AA or AG genotypes have a greater risk of developing ocular toxoplasmosis (4% greater), which may be associated with a strong and persistent inflammatory response in ocular tissue.
publishDate 2018
dc.date.issued.fl_str_mv 2018-09-26
dc.date.accessioned.fl_str_mv 2019-05-31T18:18:41Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv Faria Junior, Geraldo Magela de. Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular. 2018. 57 f. Dissertação (Programa de Pós-Graduação em Ciências da Saúde) - Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto.
dc.identifier.uri.fl_str_mv http://bdtd.famerp.br/handle/tede/534
dc.identifier.doi.por.fl_str_mv 1418
identifier_str_mv Faria Junior, Geraldo Magela de. Avaliação dos polimorfismos CCR5 32 e CCR5 59029 A/G na toxoplasmose ocular. 2018. 57 f. Dissertação (Programa de Pós-Graduação em Ciências da Saúde) - Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto.
1418
url http://bdtd.famerp.br/handle/tede/534
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv -6954410853678806574
dc.relation.confidence.fl_str_mv 500
500
600
600
dc.relation.department.fl_str_mv 306626487509624506
dc.relation.cnpq.fl_str_mv 8765449414823306929
dc.relation.sponsorship.fl_str_mv 2075167498588264571
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Faculdade de Medicina de São José do Rio Preto
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências da Saúde
dc.publisher.initials.fl_str_mv FAMERP
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Faculdade 1::Departamento 1
publisher.none.fl_str_mv Faculdade de Medicina de São José do Rio Preto
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da FAMERP
instname:Faculdade de Medicina de São José do Rio Preto (FAMERP)
instacron:FAMERP
instname_str Faculdade de Medicina de São José do Rio Preto (FAMERP)
instacron_str FAMERP
institution FAMERP
reponame_str Biblioteca Digital de Teses e Dissertações da FAMERP
collection Biblioteca Digital de Teses e Dissertações da FAMERP
bitstream.url.fl_str_mv
http://bdtd.famerp.br/bitstream/tede/534/2/GeraldoMageladeFariaJunior_Dissert.pdf http://bdtd.famerp.br/bitstream/tede/534/1/license.txt
bitstream.checksum.fl_str_mv 4d03ecdd537b8863699881831f5819ab
bd3efa91386c1718a7f26a329fdcb468
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da FAMERP - Faculdade de Medicina de São José do Rio Preto (FAMERP)
repository.mail.fl_str_mv sbdc@famerp.br||joao.junior@famerp.br
_version_ 1809113756616097792